Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Non-Erosive Reflux Disease 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Gastroesophageal Reflux 1Fatigue 1Familial primary gastric lymphoma 1Delayed Bleeding 1Barrett Esophagus 1

Interventions

Cyclophosphamide 9Radiotherapy 5Rituximab 4Peripheral Blood Stem Cell Transplantation 4Cyclosporine 4fludarabine phosphate 3Melphalan 3Indium 3Filgrastim 3Dexamethasone 3sargramostim 2epratuzumab 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Metronidazole 2Lym-1 monoclonal antibody 2Lenalidomide 2Interferon-alpha 2Idarubicin 2Etoposide 2Cytarabine 2Clarithromycin 2Cisplatin 2Busulfan 2Antilymphocyte Serum 2Amoxicillin 2motesanib diphosphate 1ledipasvir, sofosbuvir drug combination 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, B-Cell, Marginal Zone × Proton Pump Inhibitors × Clear all
NCT00154440 2007-03-26

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Technische Universität Dresden

Phase 3 Unknown
200 enrolled
GastrointestinalLymphoid

Familial primary gastric lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡